| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.14B | 17.26B | 16.79B | 15.22B | 16.49B | 15.11B |
| Gross Profit | 5.44B | 4.93B | 5.20B | 4.51B | 5.08B | 4.89B |
| EBITDA | 2.47B | 1.95B | 2.46B | 1.73B | 2.42B | 2.47B |
| Net Income | 1.68B | 1.27B | 2.01B | 1.36B | 1.39B | 1.58B |
Balance Sheet | ||||||
| Total Assets | 32.56B | 34.74B | 33.99B | 32.42B | 30.63B | 29.39B |
| Cash, Cash Equivalents and Short-Term Investments | 12.64B | 11.23B | 13.14B | 12.34B | 10.57B | 10.04B |
| Total Debt | 1.86B | 46.70M | 182.75M | 98.88M | 120.12M | 142.82M |
| Total Liabilities | 4.99B | 5.44B | 5.58B | 5.01B | 4.93B | 5.04B |
| Stockholders Equity | 27.01B | 28.67B | 27.79B | 26.78B | 25.13B | 23.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.30B | 948.44M | 2.37B | 774.35M | 1.20B |
| Operating Cash Flow | 0.00 | 1.93B | 1.81B | 2.92B | 1.63B | 1.79B |
| Investing Cash Flow | 0.00 | -2.37B | 228.10M | -87.21M | -534.70M | -757.38M |
| Financing Cash Flow | 0.00 | -1.63B | -1.28B | -1.27B | -750.66M | -648.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥12.02B | 11.32 | ― | 3.02% | 3.53% | -0.12% | |
74 Outperform | ¥128.74B | 7.89 | 8.07% | 2.64% | 81.06% | 65.92% | |
70 Neutral | ¥27.61B | 19.72 | ― | 3.16% | 2.78% | -35.76% | |
69 Neutral | ¥7.90T | 43.08 | 32.32% | 0.91% | 20.73% | 72.44% | |
68 Neutral | ¥3.47T | 27.94 | 10.06% | 1.21% | 8.80% | 117.61% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥56.10B | -60.12 | ― | 5.01% | -25.54% | -166.77% |